ACCUSTEM SCIENCES, INC.

ACUT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents
Accounts Receivable
Inventory
Total Current Assets $106.2K $49.5K $49.4K $1.6M $1.6M $1.6M $50.4K $102.5K
Property, Plant & Equipment $105 $418 $1.3K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $1.6M $1.5M $1.5M $1.6M $1.6M $1.6M $50.9K $103.8K
Liabilities
Accounts Payable $615.6K $737.5K $703.8K $923.2K $859.9K $849.1K $804.6K $790.2K
Total Current Liabilities $5.7M $5.4M $5.0M $4.5M $4.1M $3.7M $3.4M $3.3M
Long-Term Debt
Total Liabilities $5.7M $5.4M $5.0M $4.5M $4.1M $3.7M $3.4M $3.3M
Stockholders' Equity
Retained Earnings $-10.5M $-10.3M $-9.8M $-9.3M $-8.9M $-8.5M $-8.0M $-7.7M
Total Stockholders' Equity $-4.1M $-3.9M $-3.4M $-2.9M $-2.5M $-2.2M $-3.3M $-3.2M
← Newer Page 1 of 3 Older →